Carmen Bozic

CIK: 0001790029

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (39.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (26.1%)

Compensation grants

Other (G, F, J, C, D, …)8 (34.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VRTX

VERTEX PHARMACEUTICALS INC / MA

Officer

Discretionary Trading P&L

Holdings

Transaction History (23 total)

VRTX
VERTEX PHARMACEUTICALS INC / MA
Jun 26, 2026
Sale(S)
Direct
596 shares at avg. $482.50$288K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jun 18, 2026
Sale(S)
Direct
1K shares at avg. $462.17$471K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jun 15, 2026
Sale(S)
Direct
4.1K shares at avg. $450.00$1.8M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jun 5, 2026
Sale(S)
Direct
1.7K shares at avg. $450.00$785K
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 29, 2026
Sale(S)
Direct
2K shares at avg. $450.00$888K
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 15, 2026
Sale(S)
Direct
1.4K shares at avg. $453.45$614K
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 12, 2026
Sale(S)
Direct
7K shares at avg. $450.00$3.1M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Mar 13, 2026
Sale(S)
Direct
2.3K shares at avg. $481.79$1.1M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 27, 2026
Sale(S)
Direct
2.3K shares at avg. $480.31$1.1M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 24, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $485.11$705K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 17, 2026
Tax Payment(F)
Direct
1.9K shares at avg. $483.75$925K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 17, 2026
Award(A)
Direct
5.4K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 13, 2026
Tax Payment(F)
Direct
3.8K shares at avg. $487.76$1.9M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 10, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $468.41$1.0M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 22, 2026
Award(A)
Direct
3.5K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 22, 2026
Award(A)
Direct
7.9K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 26, 2025
Tax Payment(F)
Direct
5K shares at avg. $479.61$2.4M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 24, 2025
Tax Payment(F)
Direct
3.3K shares at avg. $483.28$1.6M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 14, 2025
Tax Payment(F)
Direct
1.9K shares at avg. $463.46$886K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 12, 2025
Award(A)
Direct
5.5K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 10, 2025
Tax Payment(F)
Direct
2.1K shares at avg. $467.98$1.0M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 4, 2025
Award(A)
Direct
10.3K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 4, 2025
Award(A)
Direct
5.9K shares-

		Type	Shares	Price		Ownership
Jun 26, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	596	$482.50	$287,570	Direct
Jun 18, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	1,020	$462.17	$471,413	Direct
Jun 15, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	4,062	$450.00	$1,827,900	Direct
Jun 5, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	1,745	$450.00	$785,250	Direct
May 29, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	1,974	$450.00	$888,300	Direct
May 15, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	1,354	$453.45	$613,971	Direct
May 12, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	6,988	$450.00	$3,144,600	Direct
Mar 13, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	2,329	$481.79	$1,122,089	Direct
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	2,329	$480.31	$1,118,642	Direct
Feb 24, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	1,453	$485.11	$704,865	Direct
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	1,912	$483.75	$924,930	Direct
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	5,375	-	$0	Direct
Feb 13, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	3,804	$487.76	$1,855,439	Direct
Feb 10, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,145	$468.41	$1,004,739	Direct
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	3,467	-	$0	Direct
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	7,866	-	$0	Direct
Feb 26, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	4,962	$479.61	$2,379,825	Direct
Feb 24, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	3,310	$483.28	$1,599,657	Direct
Feb 14, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	1,912	$463.46	$886,136	Direct
Feb 12, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	5,546	-	-	Direct
Feb 10, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,142	$467.98	$1,002,413	Direct
Feb 4, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	10,262	-	-	Direct
Feb 4, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	5,928	-	-	Direct

1-23 of 23 transactions

About Bozic Carmen

Bozic Carmen (SEC CIK 0001790029) files insider reports with the SEC as EVP and CMO of VERTEX PHARMACEUTICALS INC / MA (VRTX).

Signal8 holds 20 ownership filings by Bozic Carmen, all Form 4s, filed between Feb 6, 2025 and Jun 30, 2026. Those filings report 23 transactions, from Feb 4, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bozic Carmen's filings is in BOSTON, MA.

Recent filings by Bozic Carmen

Jun 26, 2026: Open-market sale of VRTX shares (Form 4, code S).
Jun 18, 2026: Open-market sale of VRTX shares (Form 4, code S).
Jun 15, 2026: Open-market sale of VRTX shares (Form 4, code S).
Jun 5, 2026: Open-market sale of VRTX shares (Form 4, code S).
May 29, 2026: Open-market sale of VRTX shares (Form 4, code S).

Other insiders filing for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Brennan Daniel J., Director
SACHS BRUCE I, Director
Garber Alan M, Director
van Grunsven Jasper, EVP, CP and NPPO
Ambrose Kristen, SVP & Chief Accounting Officer
Tatsis Ourania, EVP, Chief Reg. & Quality Off.

How to read Form 4 transaction codes